• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer
  • Home
  • Subscribe
  • Your Membership
    • Edit Your Profile
  • Services
    • Advertising
    • Case studies
    • Design
    • Email marketing
    • Lead generation
    • Magazine
    • Press releases
    • Publishing
    • Sponsored posts
    • Webcasting
    • Webinars
    • White papers
    • Writing
  • Shop
    • My Account
    • Cart
  • About
    • Contact
    • Privacy
    • Terms of use
  • Events

Robotics & Automation News

Market trends and business perspectives

  • News
  • Features
  • Video
  • Webinars
  • White papers
  • Press releases
  • Featured companies
    • AMD Xilinx
    • BlueBotics
    • Elite Robot
    • RGo Robotics
    • SICK Sensor Intelligence
    • Vicor Power

Siemens to acquire robotic surgery systems maker Corindus for $1.1 billion

August 13, 2019 by David Edwards

Siemens Healthineers is set to acquire what the company describes as a “forerunner in robotic-assisted vascular interventions”, Corindus Vascular Robotics.

The engineering giant says the acquisition of Corindus is a “strategically significant extension of Siemens Healthineers’ Advanced Therapies business”.

Siemens Healthineers will combine its cardiovascular and neuro-interventional therapy systems with Corindus’ technology, driving procedure optimization for image-based minimally invasive therapies.

Under the terms of the agreement, Siemens Healthineers will acquire all fully diluted shares of Corindus for $1.1 billion.

Bernd Montag, CEO of Siemens Healthineers, says: “Together with Corindus, Siemens Healthineers is well-positioned to be one of the leading players in the field of robotic vascular interventions and to perform minimally invasive procedures more accurately, more quickly and more effectively.

“With this acquisition, we are opening up a new field for our image-guided therapies business. Together with our strong portfolio in imaging, digitalization and artificial intelligence, we are creating significant synergies to advance therapy outcomes.”

Mark Toland, president and CEO at Corindus, says: “The collaboration with Siemens Healthineers is a unique opportunity to take our business to the next level and continue our success story. Together we plan to develop next-generation solutions that further improve patient care.”

Siemens, a German company, describes the deal as a “merger agreement”, and says the US-based Corindus is “a global technology leader for robotic-assisted vascular interventions”.

Under the terms of the agreement, Siemens Healthineers will acquire all fully diluted shares of Corindus for $4.28 per share in cash or $1.1 billion in total.

The transaction is expected to be closed by end of calendar year 2019, subject to Corindus shareholder approval, receipt of regulatory approvals and other customary closing conditions. The Corindus board fully supports the acquisition proposal.

Corindus is headquartered in Waltham, Boston, Massachusetts, and currently has approximately 100 employees.

Corindus develops, produces and sells robotic systems for minimally invasive procedures. These systems help doctors to precisely control guide catheters, guide wires, balloon or stent implants via integrated imaging.

The physician does not have to stand at the angiography table as usual but can control the procedure with a separate controlling module and is, therefore, less exposed to radiation.

Corindus is currently one of the leading companies offering a robotic treatment platform for major vascular therapeutic markets, meaning coronary, peripheral vascular and neurovascular interventions. For example, heart disease is the most common cause of death in the US.

Every year, more than 4 million percutaneous coronary interventions are carried out worldwide.

The acquisition of Corindus meets the objective of simplifying today’s challenges in everyday hospital life.

Robotic-assisted minimally invasive procedures have the potential to reduce treatment times, increase precision during treatment, raise standardization levels in clinical procedures and ultimately improve clinical outcomes, which is the strategic focus of the Advanced Therapies business segment.

Michel Therin, president advanced therapies at Siemens Healthineers, says: “The interplay of exact imaging and robotic-assisted interventions will enhance both the eyes and hands of the physician, metaphorically speaking.

“With the addition of Corindus to our strong therapies portfolio we sharpen our procedural focus and will grow by expanding precision medicine and improving clinical outcomes. In the future, our digital and artificial intelligence-based tools will help to integrate the aspects of image-guidance and therapy even further.”

The CorPath systems developed by Corindus will be used together with angiography systems that Siemens Healthineers sells as one of the leading suppliers.

The Siemens Healthineers products make minimally invasive treatment possible by using high-quality imaging before and during medical interventions.

The company’s leading role in image-based minimally invasive procedures is now complemented by robotic-assisted precision medicine.

This expansion strengthens the therapy position of Siemens Healthineers and underlines its role as one of the leading providers of solutions along the entire treatment path.

This makes the acquisition of Corindus a strategically significant extension of Siemens Healthineers’ therapy business.

The future integration of Siemens Healthineers digitization and artificial intelligence solutions with Corindus’ robotic systems offers further promising possibilities.

The aim is to further increase procedure optimization in order to enable the greatest possible degree of efficiency and clinical reproducibility.

In addition, Corindus is driving forward the approval procedure for remote robotic treatment in vascular interventions.

Due to the limited availability of specialists for minimally invasive procedures in many regions and the limited number of corresponding clinical facilities, remote treatment could significantly improve patients’ access to treatment in the future, says Siemens.

Print Friendly, PDF & Email

Share this:

  • Print
  • Facebook
  • LinkedIn
  • Reddit
  • Twitter
  • Tumblr
  • Pinterest
  • Skype
  • WhatsApp
  • Telegram
  • Pocket

You might also like…

Filed Under: Industry, News Tagged With: corindus, healthineers, interventions, invasive, minimally, procedures, robotic, siemens, systems, therapies, treatment, vascular

Join the Robotics & Automation News community

Primary Sidebar

Latest articles

  • 4Ocean robot cleans up Florida beach as part of startup’s mission to clean up the world’s oceans
  • Kuka releases ‘one of the strongest and fastest delta robots on the market’
  • Roundtable Discussion: Industry experts help you plan your approach to investing in AGVs and AMRs
  • Hannover Messe planning to be a ‘showcase for artificial intelligence’ this year
  • Abu Dhabi’s SkyGo invests in commercial drones provider Airobotics for goods transportation
  • Rapid Robotics partners with Yaskawa Motoman to expand solutions for industrial robotic arms
  • Nidec Leroy-Somer selected by Airbus to develop electric motors for its future hydrogen powered zero-emission engine
  • Apptronik and Terex to jointly develop robots for commercial use
  • Visteon and Steradian partner to develop autonomous car functions
  • Hyundai launches delivery robot pilot programs

Most Read

  • Top 20 electric vehicle charging station companies
    Top 20 electric vehicle charging station companies
  • Top 20 programmable logic controller manufacturers
    Top 20 programmable logic controller manufacturers
  • Difference Between Three-Phase and Single-Phase Power
    Difference Between Three-Phase and Single-Phase Power
  • Why is My Car Key Stuck in the Ignition?
    Why is My Car Key Stuck in the Ignition?
  • Thermo Fisher Scientific partners with Celltrio to build fully automated cell culture system
    Thermo Fisher Scientific partners with Celltrio to build fully automated cell culture system
  • Hyundai launches delivery robot pilot programs
    Hyundai launches delivery robot pilot programs
  • Manufactured in the metaverse: Mercedes-Benz designs virtual factories with Nvidia Omniverse
    Manufactured in the metaverse: Mercedes-Benz designs virtual factories with Nvidia Omniverse
  • Foxconn plans to build autonomous vehicles on Nvidia computing platform
    Foxconn plans to build autonomous vehicles on Nvidia computing platform
  • The Best Mechanical Engineering Design Software in 2022
    The Best Mechanical Engineering Design Software in 2022
  • Kuka unveils new compact autonomous mobile robot for intralogistics
    Kuka unveils new compact autonomous mobile robot for intralogistics

Overused words

ai applications automated automation automotive autonomous business china companies company control customers data design development digital electric global industrial industry logistics machine manufacturing market mobile platform process production robot robotic robotics robots safety software solution solutions system systems technologies technology time vehicle vehicles warehouse work

Secondary Sidebar

Latest news

  • 4Ocean robot cleans up Florida beach as part of startup’s mission to clean up the world’s oceans
  • Kuka releases ‘one of the strongest and fastest delta robots on the market’
  • Roundtable Discussion: Industry experts help you plan your approach to investing in AGVs and AMRs
  • Hannover Messe planning to be a ‘showcase for artificial intelligence’ this year
  • Abu Dhabi’s SkyGo invests in commercial drones provider Airobotics for goods transportation
  • Rapid Robotics partners with Yaskawa Motoman to expand solutions for industrial robotic arms
  • Nidec Leroy-Somer selected by Airbus to develop electric motors for its future hydrogen powered zero-emission engine
  • Apptronik and Terex to jointly develop robots for commercial use
  • Visteon and Steradian partner to develop autonomous car functions
  • Hyundai launches delivery robot pilot programs

Footer

We are…

Robotics and Automation News was established in May, 2015, and is now one of the most widely-read websites in its category.

Please consider supporting us by becoming a paying subscriber, or through advertising and sponsorships, or by purchasing products and services through our shop – or a combination of all of the above.

Thank you.

Independent

Archivists

August 2019
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
« Jul   Sep »

Complex

Old-skool

This website and its associated magazine, and weekly newsletter, are all produced by a small team of experienced journalists and media professionals.

If you have any suggestions or comments, feel free to contact us at any of the email addresses on our contact page.

We’d be happy to hear from you, and will always reply as soon as possible.

Future-facing

Free, fair and legal

We support the principles of net neutrality and equal opportunities.

Member of The Internet Defense League

Copyright © 2023 · News Pro on Genesis Framework · WordPress · Log in

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie SettingsAccept
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT